This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: To test the hypotheses that older community dwelling men taking non–enzyme-inducing antiepileptic drugs (NEIAEDs) and those taking enzyme-inducing antiepileptic drugs (EIAEDs) have increased rates of hip bone loss.
Methods: We ascertained antiepileptic drug (AED) use (interviewer-administered questionnaire with verification of use by containers) and measured hip bone mineral density (BMD) (using dual energy x-ray absorptiometry) at baseline and an average of 4.6 years later in a cohort of 4,222 older community-dwelling men enrolled in the Osteoporotic Fractures in Men study. Men were categorized as nonusers (no AED use at either examination, n = 4060), NEIAED user (use of NEIAED only at either examination, n = 100), or EIAED user (use of EIAED only at either examination, n = 62).
Results: After adjustment for multiple potential confounders (age, race, clinic site, health status, pain interfering with work or activity, physical activity, smoking status, alcohol use, total calcium intake, diabetes, chronic kidney disease, vitamin D supplement use, bisphosphonate use, selective serotonin reuptake inhibitor use, inability to rise from a chair, body mass index, and baseline BMD), the average rate of decline in total hip BMD was −0.35%/year among nonusers compared with −0.53%/year among NEIAED users (p = 0.04) and −0.46%/year among EIAED users (p = 0.31). Multivariable adjusted rate of loss was −0.60%/year among men taking NEIAED at both examinations, −0.51%/year among men taking NEIAED at one examination only, and −0.35%/year among nonusers (p for trend = 0.03). Findings were similar at hip subregions.
Conclusion: Use of non–enzyme-inducing antiepileptic drugs was independently associated with increased rates of hip bone loss in this cohort of older community-dwelling men.
Glossary
- AED=
- antiepileptic drug;
- BMD=
- bone mineral density;
- CKD=
- chronic kidney disease;
- CV=
- coefficient of variation;
- DXA=
- dual energy x-ray absorptiometry;
- EIAED=
- enzyme-inducing antiepileptic drugs;
- IDIS=
- Iowa Drug Information Service;
- MrOS=
- Osteoporotic Fractures in Men;
- NEIAED=
- non–enzyme-inducing antiepileptic drugs;
- PASE=
- Physical Activity Scale for the Elderly;
- SOF=
- Study of Osteoporotic Fractures;
- SSRI=
- selective serotonin reuptake inhibitors.
AAN Members: Sign in with your AAN member credentials (e-mail or 6-digit Member ID number)
Non-AAN Member subscribers: Sign in with subscriber credentials
Log in using your username and password
Purchase access
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.